Advertisement

Proximity (ProxiMol) and Step-Back Selections

  • Jane K. Osbourn
Part of the Springer Lab Manuals book series (SLM)

Abstract

Other chapters in this volume describe the selection of antibodies specific to cell surface molecules in a non-guided manner. Cell surfaces are antigenically complex and this results in difficulties in specifically selecting antibodies which bind to a given cell surface molecule without selecting for a host of unwanted specificities in parallel. The desired antigen specificity can in many cases be obtained, but only after an intensive screening programme has been undertaken. One of the rationales for the development of ProxiMol selection (previously known as Pathfinder selection) was to provide an efficient method for the generation of a population of antibodies enriched for binders which bind in close proximity to a particular desired cell surface antigen alleviating the necessity for labour intensive screening programmes. This selection regime greatly narrows the scope of the selection and increases the probability of selecting antibodies of interest.

Keywords

Target Antigen Cell Surface Molecule Phage Particle Guide Molecule Phage Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams JC. (1992). Biotin amplification of biotin and horseradish peroxidae signals in histochemical stains J Histochem Cytochem 40 1457–1463PubMedCrossRefGoogle Scholar
  2. Bobrow MN, Harris TD, Shaughnessy KJ, Litt GJ (1989) Catalyzed reported deposition, a novel method of signal amplification. J Immunol Methods 125 279–285PubMedCrossRefGoogle Scholar
  3. Bobrow MN, Litt GJ, Shaughnessy KJ, Mayer PC and Colon J (1992). The use of catalysed reported deposition as a means of signal amplification in a variety of formats. J Immunol Method 150 145–149CrossRefGoogle Scholar
  4. Merz H, Malisius R, Mannweiler S, Zhou R, Hartmann W, Orscheschek K, Moubayed P, Feller AC (1995). A maximised immunohistochemical method for the retrival and enhancement of hidden antigens. Lab Invest 73 149–156PubMedGoogle Scholar
  5. Osbourn JK, Derbyshire EJ, Vaughan TJ, Field AW, Johnson KS (1998a). Pathfinder selection; in situ isolation of novel antibodies. Immunotechnology 3 293–302PubMedCrossRefGoogle Scholar
  6. Osbourn JK, Earnshaw JC, Johnson KS, Parmentier M, Timmermans V, McCafferty J (1998b). Directed selection of MIP-1 a neutralizing CCR5 antibodies from a phage display human antibody library. Nature Biotech 16 778–781CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2001

Authors and Affiliations

  1. 1.Cambridge Antibody TechnologyThe Science ParkMelbourn, CambridgeshireUK

Personalised recommendations